A detailed history of Wood Trust Financial Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wood Trust Financial Corp holds 13,726 shares of BMY stock, worth $672,299. This represents 0.12% of its overall portfolio holdings.

Number of Shares
13,726
Previous 9,917 38.41%
Holding current value
$672,299
Previous $508,000 46.46%
% of portfolio
0.12%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$47.98 - $54.4 $182,755 - $207,209
3,809 Added 38.41%
13,726 $744,000
Q4 2023

Jan 23, 2024

SELL
$48.48 - $57.85 $96,960 - $115,700
-2,000 Reduced 16.78%
9,917 $508,000
Q3 2023

Oct 16, 2023

BUY
$57.89 - $64.73 $17,367 - $19,419
300 Added 2.58%
11,917 $692,000
Q3 2022

Oct 28, 2022

BUY
$0.13 - $76.84 $16 - $9,758
127 Added 1.11%
11,617 $825,000
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $64,356 - $75,024
1,200 Added 11.66%
11,490 $716,000
Q3 2021

Nov 08, 2021

BUY
$59.17 - $69.31 $171,178 - $200,513
2,893 Added 39.11%
10,290 $609,000
Q2 2021

Aug 03, 2021

BUY
$61.91 - $67.42 $34,483 - $37,552
557 Added 8.14%
7,397 $494,000
Q1 2021

Apr 22, 2021

SELL
$59.34 - $66.74 $58,924 - $66,272
-993 Reduced 12.68%
6,840 $432,000
Q4 2020

Jan 21, 2021

BUY
$57.74 - $65.43 $4,215 - $4,776
73 Added 0.94%
7,833 $486,000
Q2 2020

Jul 29, 2020

SELL
$54.82 - $64.09 $21,928 - $25,636
-400 Reduced 4.9%
7,760 $456,000
Q4 2019

Jan 21, 2020

BUY
$49.21 - $64.19 $44,928 - $58,605
913 Added 12.6%
8,160 $524,000
Q3 2019

Oct 15, 2019

SELL
$42.77 - $50.71 $36,226 - $42,951
-847 Reduced 10.46%
7,247 $367,000
Q2 2019

Jul 15, 2019

BUY
$44.62 - $49.34 $1,918 - $2,121
43 Added 0.53%
8,094 $367,000
Q1 2018

Apr 18, 2018

SELL
$59.92 - $68.98 $4,613 - $5,311
-77 Reduced 0.95%
8,051 $509,000
Q4 2017

Jan 23, 2018

BUY
$59.94 - $65.35 $487,192 - $531,164
8,128
8,128 $498,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $104B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wood Trust Financial Corp Portfolio

Follow Wood Trust Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wood Trust Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Wood Trust Financial Corp with notifications on news.